These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36872786)

  • 1. Oculomotor Dysfunction in Motor Neuron Disease.
    Youn CE; Lu C; Cauchi J; MacGowan D; Morgenstern R; Scelsa S
    J Neuromuscul Dis; 2023; 10(3):405-410. PubMed ID: 36872786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43 in differential diagnosis of motor neuron disorders.
    Dickson DW; Josephs KA; Amador-Ortiz C
    Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical motor neuron disease and related motor syndromes.
    Verma A; Bradley WG
    Semin Neurol; 2001 Jun; 21(2):177-87. PubMed ID: 11442326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal Dementia.
    Cortés-Vicente E; Turon-Sans J; Gelpi E; Clarimón J; Borrego-Écija S; Dols-Icardo O; Illán-Gala I; Lleó A; Illa I; Blesa R; Al-Chalabi A; Rojas-García R
    Dement Geriatr Cogn Disord; 2018; 45(3-4):220-231. PubMed ID: 29886477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
    Conde B; Winck JC; Azevedo LF
    Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor neuron disease beginning with frontotemporal dementia: clinical features and progression.
    Gromicho M; Kuzma-Kozakiewicz M; Szacka K; Nieporecki K; Andersen PM; Grosskreutz J; Petri S; Pinto S; Uysal H; Swash M; De Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):508-516. PubMed ID: 34229542
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND.
    McHutchison CA; Leighton DJ; McIntosh A; Cleary E; Warner J; Porteous M; Chandran S; Pal S; Abrahams S
    J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):245-253. PubMed ID: 31871139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed pathologies mimicking motor neuron disease: a case report and review of the literature.
    Dey A; Assaedi E; Johnston W; Kalra S; Das S
    Folia Neuropathol; 2021; 59(4):403-408. PubMed ID: 35114781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates.
    Vinceti G; Olney N; Mandelli ML; Spina S; Hubbard HI; Santos-Santos MA; Watson C; Miller ZA; Lomen-Hoerth C; Nichelli P; Miller BL; Grinberg LT; Seeley WW; Gorno-Tempini ML
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):146-158. PubMed ID: 30668155
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease.
    Olney NT; Bischof A; Rosen H; Caverzasi E; Stern WA; Lomen-Hoerth C; Miller BL; Henry RG; Papinutto N
    PLoS One; 2018; 13(11):e0208255. PubMed ID: 30496320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis.
    Statland JM; Barohn RJ; McVey AL; Katz JS; Dimachkie MM
    Neurol Clin; 2015 Nov; 33(4):735-48. PubMed ID: 26515618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyotrophic lateral sclerosis or not: Keys for the diagnosis.
    Lenglet T; Camdessanché JP
    Rev Neurol (Paris); 2017 May; 173(5):280-287. PubMed ID: 28461025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor neuron disease in patients with HIV infection: Report of two cases and brief review of the literature.
    Lorenzoni PJ; Ducci RD; Dalledone GO; Kay CSK; de Almeida SM; Werneck LC; Scola RH
    Clin Neurol Neurosurg; 2018 Aug; 171():139-142. PubMed ID: 29909186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
    Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontotemporal dementia and motor neuron disease: report of 3 cases in Taiwan and literature review.
    Chen KH; Chiu MJ; Cheng TW; Su JJ
    Acta Neurol Taiwan; 2011 Sep; 20(3):202-8. PubMed ID: 22009125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Dysphagia in Motor Neuron Disease. Review of Available Diagnostic Tools and New Perspectives.
    Romero-Gangonells E; Virgili-Casas MN; Dominguez-Rubio R; Povedano M; Pérez-Saborit N; Calvo-Malvar N; Barceló MA
    Dysphagia; 2021 Aug; 36(4):558-573. PubMed ID: 32797289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical technology assessment. Electrodiagnosis in motor neuron diseases and amyotrophic lateral sclerosis.
    de Carvalho M; Johnsen B; Fuglsang-Frederiksen A
    Neurophysiol Clin; 2001 Oct; 31(5):341-8. PubMed ID: 11817274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.
    van Blitterswijk M; DeJesus-Hernandez M; Niemantsverdriet E; Murray ME; Heckman MG; Diehl NN; Brown PH; Baker MC; Finch NA; Bauer PO; Serrano G; Beach TG; Josephs KA; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Boylan KB; Petrucelli L; Dickson DW; Rademakers R
    Lancet Neurol; 2013 Oct; 12(10):978-88. PubMed ID: 24011653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes.
    Gilbert RM; Fahn S; Mitsumoto H; Rowland LP
    Mov Disord; 2010 Sep; 25(12):1868-75. PubMed ID: 20669307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocol.
    Beswick E; Glasmacher SA; Dakin R; Newton J; Carson A; Abrahams S; Chandran S; Pal S
    BMJ Open; 2021 Mar; 11(3):e044996. PubMed ID: 33757953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.